Old Web
English
Sign In
Acemap
>
authorDetail
>
Ling Wei
Ling Wei
Science Applications International Corporation
Panitumumab
Nuclear medicine
Epidermal growth factor receptor
Positron emission tomography
Dosimetry
4
Papers
58
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Preparation of clinical‐grade 89Zr‐panitumumab as a positron emission tomography biomarker for evaluating epidermal growth factor receptor‐targeted therapy
2014
Journal of Labelled Compounds and Radiopharmaceuticals
Ling Wei
Jianfeng Shi
George Afari
Sibaprasad Bhattacharyya
Show All
Source
Cite
Save
Citations (11)
Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas
2013
Nuclear Medicine and Biology
Sibaprasad Bhattacharyya
Karen Kurdziel
Ling Wei
Lisa Riffle
Gurmeet Kaur
G. Craig Hill
Paula M. Jacobs
James L. Tatum
James H. Doroshow
Joseph D. Kalen
Show All
Source
Cite
Save
Citations (45)
Murine biodistribution and human dosimetry estimates of 111In DTPA- and 89Zr DFO-panitumumab
2012
The Journal of Nuclear Medicine
Karen Kurdziel
Joseph D. Kalen
Sibaprasad Bhattacharyya
Lisa Riffle
Ling Wei
G. Hill
James H. Doroshow
Paula M. Jacobs
James L. Tatum
Show All
Source
Cite
Save
Citations (1)
Preparation of 111In labeled radiopharmaceuticals using radio-labeling kit developed by the National Cancer Institute (NCI)
2010
The Journal of Nuclear Medicine
Sibaprasad Bhattacharyya
Ling Wei
Manish Dixit
G. Hill
Show All
Source
Cite
Save
Citations (1)
1